Article Information
- Received November 26, 2016
- Revision received September 4, 2017
- Revision received September 7, 2017
- First published September 14, 2017.
- Version of record published October 18, 2017.
Author Information
- Ryota Nakazato1,
- Kenji Kawabe2,
- Daisuke Yamada2,
- Shinsuke Ikeno1,
- Michihiro Mieda3,
- Shigeki Shimba4,
- Eiichi Hinoi1,
- Yukio Yoneda1, and
- Takeshi Takarada1,2
- 1Laboratory of Molecular Pharmacology, Division of Pharmaceutical Sciences, Kanazawa University Graduate School, Kanazawa, Ishikawa 920-1192, Japan,
- 2Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan,
- 3Department of Molecular Neuroscience and Integrative Physiology, Faculty of Medicine, Kanazawa University, Kanazawa, Ishikawa 920-8640, Japan, and
- 4Department of Health Science, College of Pharmacy, Nihon University, Chiba 274-8555, Japan
Author contributions
Author contributions: K.K., D.Y., E.H., Y.Y., and T.T. designed research; R.N., K.K., and S.I. performed research; M.M. and S.S. contributed unpublished reagents/analytic tools; R.N. and S.I. analyzed data; R.N., K.K., D.Y., and T.T. wrote the paper.
Disclosures
- Received November 26, 2016.
- Revision received September 4, 2017.
- Revision received September 7, 2017.
This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas (26117507 and 16H01332) and for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) to T.T. from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and in part by a research grant to T.T. from the Nakatomi Foundation. We thank Dr. G. Enikolopov (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY), Dr. Jamey D. Marth (University of California, Santa Barbara, Santa Barbara, CA), and Dr. Shigeyoshi Itohara (RIKEN Brain Science Institute, Saitama, Japan) for generously providing the Nestin-GFP, Synapsin I-Cre, and S100β-Cre mice, respectively.
The authors declare no competing financial interests.
- Correspondence should be addressed to Takeshi Takarada, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan. takarada{at}okayama-u.ac.jp
Other Version
- previous version (September 14, 2017).
- You are viewing the most recent version of this article.
Online Impact